Regulatory Measures Could Mitigate Coronavirus Risks In Europe
More Flexible Procedures Will Be Needed, Says Off-Patent Industry
As part of its response to the coronavirus outbreak, the European association representing generic and biosimilar drug companies, Medicines for Europe, has set out a series of policy recommendations that it says could help to mitigate the possible risks to medicines supply.
